WebDisclosure WebDisclosure
Basculer en Français
10964 Companies
240036 Keywords
168778 Articles
129136 Press releases
Headlines Articles Press releases Saint James School Of Medicine Remove
  1. Home
  2. Companies
  3. Saint James School Of Medicine
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/04/2024 at 17:10, 2 years 6 months ago

    L'École de médecine Saint James célèbre 25 ans d'excellence en éducation médicale

    École De Médecine Saint James 25ème Anniversaire Ecole De Médecine Des Caraïbes Éducation Médicale Professionnels De La Santé
  • PRESS RELEASE

    published on 03/04/2024 at 17:05, 2 years 6 months ago

    Saint James School of Medicine Celebrates 25 Years of Excellence in Medical Education

    Saint James School of Medicine in the Caribbean celebrates its 25th anniversary, focusing on quality medical education and student success
    Medical Education Student Success Saint James School Of Medicine 25th Anniversary Caribbean
    Logo of Saint James School Of Medicine
Previous page
1 2
Accesswire
  • Published on 09/11/2026 at 04:00, 7 hours 47 minutes ago

    Torq Announces Debt Settlement and Corporate Update

  • Published on 09/10/2026 at 22:25, 13 hours 22 minutes ago

    Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer

  • Published on 09/10/2026 at 17:46, 18 hours 1 minute ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 20 hours 27 minutes ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 20 hours 47 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 11:35, 11 minutes ago

    EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs

  • Published on 09/11/2026 at 11:30, 17 minutes ago

    Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress

  • Published on 09/11/2026 at 10:15, 1 hour 31 minutes ago

    TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050

  • Published on 09/11/2026 at 09:20, 2 hours 26 minutes ago

    Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines

  • Published on 09/11/2026 at 09:05, 2 hours 41 minutes ago

    ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 4 hours 47 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 4 hours 47 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 4 hours 47 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 4 hours 47 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 16 hours 17 minutes ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy